Abstract
The biological significance of squamous and glandular differentiation and different patterns of invasion in upper urinary tract urothelial carcinoma is unclear. We reviewed 268 cases of consecutive upper urinary tract carcinomas with respect to the presence of squamous and/or glandular differentiation and different patterns of invasion (nodular, trabecular, and infiltrative) and correlated data with patient outcome. Squamous or glandular differentiation occurred in 47/268 (18%) tumors and its presence correlated with high tumor stage (P<0.001) and grade (P<0.001). Invasive patterns were nodular in 49/227 (22%), trabecular in 95/227 (42%), and infiltrative in 83/227 (37%) tumors. The nodular pattern prevailed in low stage (P<0.001) and low-grade (P<0.001) tumors, whereas the infiltrative pattern prevailed in high stage (P<0.001) and high-grade (P<0.001) tumors. Multivariate analysis proved that tumor stage (P<0.001) and the infiltrative pattern (P<0.001) are independent predictors of metastasis-free survival, whereas tumor grade and squamous and glandular differentiation lacked independent influence on patient outcome. In conclusion, the infiltrative pattern of invasion significantly correlated with advanced disease and poor patient outcome. In contrast, the presence of squamous and/or glandular invasion did not prove independent influence on patient outcome. The pattern of invasion should be commented upon separately in the pathology report.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Upper urinary tract urothelial carcinoma (UC) is relatively uncommon, accounting for approximately 5% of all epithelial tumors of the urinary tract with most tumors occurring in the bladder [10]. Standard treatment for localized upper tract UC is radical nephroureterectomy with bladder cuff resection [18]. Although numerous investigations showed that stage is the most important predictor of outcome [3, 5–8, 12–15, 19, 24, 31, 32, 34, 35], the clinicopathologic features predictive of metastatic disease are not well defined and the assessment of tumor grade shows considerable variation due to observer subjectivity [2, 44]. Thus, the identification of other prognostic variables that can easily be determined in routinely hematoxylin and eosin (H&E)-stained sections is required to select candidates for adjuvant therapy.
The majority of primary epithelial neoplasms of the urinary tract display conventional urothelial morphology but some tumors may additionally show aberrant differentiation thought to arise from metaplastic change [22, 39]. These areas are most frequently squamous or glandular in nature and their frequency was shown to increase with tumor grade and stage [1, 11, 42, 43, 45]. Thus, most urological oncologists share the view that mixed histology implies more aggressive disease, which may be less susceptible to radio- or chemotherapy [16, 25, 29]. However, there is only one study analyzing the prognostic impact of squamous and/or glandular differentiation in a series of 70 bladder carcinomas [30], whereas a systematical investigation analyzing the clinical significance of squamous and/or glandular differentiation in upper urinary tract cancer, including both univariate and multivariate statistical analysis, is currently lacking.
Recently, Jiminez et al. [17] described three different patters of invasion (nodular, trabecular, and infiltrative) in a series of 93 muscle-invasive bladder cancers. According to their data, the infiltrative growth pattern may be associated with unfavorable patient outcome despite lack of significance in multivariate analysis. In a subsequent study by Krüger et al. [20] involving 153 muscle-invasive bladder cancers, the infiltrative pattern proved to be an independent predictor of poor disease-related survival. The authors concluded that the classification by Jiminez et al. [17] may serve as an additional tool to predict the prognosis of patients undergoing radical cystectomy for bladder cancer.
In the present study, we aimed to evaluate the potential prognostic significance of squamous and/or glandular differentiation in a large consecutive series of upper urinary tumors. Moreover, our study is the first to apply the classification introduced by Jiminez et al. [17] to this type of urothelial cancer and to assess its role in predicting metastasis-free survival. By performing a multivariate analysis, we analyzed the potential of the different histological variables to serve as independent predictors of patient outcome.
Materials and methods
Case selection
Two hundred sixty-eight consecutive upper urinary tract UCs (169 pelvic and 99 ureteral tumors) from 239 consecutive patients (108 women and 131 men) undergoing surgery between January 1984 and December 2004 were retrieved from the files of our institute. The mean and median ages of patients were 70 and 71 years (range 39–89), respectively. Seventeen out of 239 (7%) patients presented with local lymph node metastases at the time of their primary operation. All tumor specimens were examined by the same protocol including multiple sections obtained from the tumor itself, the kidney, and the pelvic wall adjacent to and distant from the tumor, along with the ureter and lymph nodes, if present.
For the correlation of histopathological data with metastasis-free survival, all noninvasive cancers (41 tumors from 33 patients) and all tumors from patients with multiple invasive cancers (37 tumors from 16 patients) were excluded resulting in a final sample of 190 UCs (134 pelvic and 56 ureteral tumors) from 190 patients (77 women and 113 men). Standard treatment included nephroureterectomy with bladder-cuff resection (n=130), alternatively, nephrectomy alone (n=40) or distal ureteral resection with reimplantation (n=20) were performed. Patients did not receive adjuvant therapy. Follow-up regimen included abdominal ultrasound and cystoscopy every 3 months for the first 3 years, every 6 months for the subsequent 2 years, and yearly thereafter and chest X-ray and computerized tomography every 6 months for the first 3 years and yearly thereafter. All procedures were in accord with the ethical standards established by our institution. Informed consent is not required for retrospective analyses dealing with archival material obtained during routine medical treatment.
Histopathology
H&E-stained slides from routinely formalin-fixed and paraffin-embedded material were systematically reevaluated by one pathologist (C. L.) who was blinded to regional lymph node status and the subsequent disease course. pT-stages were adjusted according to the International Union Against Cancer 2002 issue of the Tumor, Nodes, Metastasis system [41]. Grading was performed according to the recently published two-tiered WHO grading system following the WHO/International Society of Urological Pathology consensus classification [27]. During the process of reviewing the slides, special attention was drawn toward the presence of aberrant histological differentiation. According to the WHO criteria for the diagnosis of histological variants of urothelial cancer [27], squamous differentiation was defined as the presence of intercellular bridges or keratinization. Glandular differentiation was defined as the presence of true glandular spaces and gland-like lumina within tumor cell nests; special care was taken to differentiate these glandular structures from pseudoglandular spaces caused by drop-out of necrotic cells or artifact. A significant proportion of tumors displayed both squamous and glandular differentiation. In these cases both patterns were recorded. Three main architectural patterns of tumor invasion were recognized following the definition by Jiminez at al. [17]: The nodular pattern was composed of well-delineated round nests of tumor cells. These nests varied in diameter but a tendency of roundness was maintained throughout (Fig. 1a). Desmoplasia was usually not prominent and necrosis was not observed. The trabecular pattern consisted of infiltrating broad trabeculae that usually anastomosed with each other and were sometimes associated with extensive necrosis and a desmoplastic stroma (Fig. 1b). The trabeculae were at lest three cells thick. The infiltrative pattern showed infiltrating narrow cords or single tumor cells (Fig. 1c). Desmoplasia and necrosis were common. Cells were usually highly pleomorphic or small and undifferentiated. Tumor heterogeneity represents a well-known phenomenon in urothelial cancers and different subclones with different phenotypes are known to coexist within the same tumor, among which, those bearing the most aggressive biological potential eventually determine patient outcome [4]. Accordingly, in cases showing two or more patterns of invasion, only the most aggressive type of tumor growth (infiltrative > trabecular > nodular) was recorded.
Statistical analyses
Associations between patterns of invasion or histological differentiation and tumor stage as well as tumor grade were analyzed using the Fisher’s exact test. Patient outcome was investigated using the Kaplan–Meier method and compared by the log-rank test. Disease progression was defined as the occurrence of nodal and/or distant metastases. Metastasis-free survival was calculated from definitive treatment of upper tract disease (e.g., nephroureterectomy) to the occurrence of metastatic disease or the last follow-up in patients with no evidence of disease progression. For multivariate testing, a Cox’s proportional hazards regression model was performed. All reported P values were two-sided with significance at P<0.05.
Results
Overall, stage pTa was present in 41 (15%), pT1 in 102 (38%), pT2 in 37 (14%), pT3 in 80 (30%), and pT4 in eight (3%) cases. One hundred forty-one (53%) tumors were of low tumor grade and 127 (47%) were of high tumor grade. Pelvic and ureteral tumors showed a comparable distribution regarding the different categories. High tumor grade was associated with high tumor stage [53/139 (38%) pT1/pT2 vs 74/88 (84%) pT3/pT4, P<0.001]; no high-grade tumors were detected among noninvasive cancers.
Squamous differentiation occurred in 47/268 (18%) tumors. The majority of them showed small interspersed islands of squamous epithelium with mild to moderate atypia in otherwise typical urothelial carcinoma (Fig. 2a). In some cases, however, poorly differentiated tumor cells showing squamous differentiation (with or without keratinization) gradually merged with the surrounding urothelial tumor cells, ultimately representing the predominant histological growth pattern (Fig. 2b). Squamous differentiation prevailed in high stage [15/180 (8%) pTa-pT2 vs 32/88 (36%) pT3/pT4, P<0.001] and high grade [8/141 (6%) low grade vs 39/127 (31%) high grade, P<0.001] cancers (Table 1).
Glandular structures were observed in 47/268 (18%) tumors. The amount of glandular differentiation was variable with the majority of cases showing only focal glands bordered by a single layer of cuboidal or columnar cells or gland-like lumina scattered among nests of otherwise typical urothelial carcinoma (Fig. 2c). In some cases, however, the glandular differentiation represented the predominating histological growth pattern (Fig. 2d). Glandular differentiation prevailed in high stage [22/180 (12%) pTa-pT2 vs 25/88 (28%) pT3/pT4, P=0.002] and high grade [17/141 (12%) low grade vs 30/127 (24%) high grade, P=0.02] cancers (Table 2). Occasionally, the glands underwent cystic dilatation, resulting in a microcystic appearance. One case displayed a colloid-mucinous pattern characterized by nests of cells “floating” in extracellular mucin. It is interesting to note that the glandular growth pattern was associated with the presence of squamous differentiation. Thus, 20/47 (43%) tumors with glandular lumina simultaneously showed foci of squamous differentiation compared with 27/221 (12%) tumors without glandular differentiation (P<0.001).
According to Jiminez et al. [17], patterns of invasion were nodular in 49/227 (22%), trabecular in 95/227 (42%), and infiltrative in 83/227 (37%) tumors. The nodular pattern prevailed in low stage [45/139 (32%) pT1/pT2 vs 4/88 (5%) pT3/pT4, P<0.001] and low grade [44/100 (44%) low grade vs 5/127 (4%) high grade, P<0.001] cancers, whereas the infiltrative pattern prevailed in high stage [20/139 (14%) pT1/pT2 vs 63/88 (72%) pT3/pT4, P<0.001] and high grade [0/100 (0%) low grade vs 83/127 (65%) high grade, P<0.001] cancers (Table 3).
Follow-up data were available from 186/190 (98%) patients. After a mean and median follow-up of 46 and 31 months, respectively, progressive disease was observed in 74/186 (40%) patients including 60 patients who died from cancer and 14 patients who are currently alive with metastatic disease. Mean time to progression was 19 months (median 8.3, range 0–110). Twenty-five patients died from causes not related to cancer. Actuarial overall and metastasis-free survival rates were 63 and 56% at 5 years and 52 and 45% at 10 years.
The development of distant metastases was associated with the presence of squamous and/or glandular differentiation. Thus, 25/43 (58%) UCs with squamous differentiation developed disease progression compared with 49/143 (34%) UCs without squamous differentiation (P=0.001; Fig. 3). Actuarial 5-year metastasis-free survival rates for patients with UCs with and without squamous differentiation were 33 and 63%, respectively. Similarly, 19/36 (53%) UCs with glandular differentiation developed disease progression, compared with 55/150 (37%) UCs without glandular differentiation (P=0.04; Fig. 4). Actuarial 5-year metastasis-free survival rates for patients with UCs with and without glandular differentiation were 45 and 59%, respectively. In addition, disease progression was associated with the pattern of invasion. Thus, only 3/41 (7%) UCs with a nodular pattern developed disease progression compared with 18/78 (23%) UCs with a trabecular pattern and 53/67 (79%) UCs with an infiltrative pattern (P<0.002; Fig. 5). Actuarial 5-year metastasis-free survival rates for UCs with nodular, trabecular, and infiltrative pattern of invasion were 94, 74, and 12%, respectively (Table 4). No significant prognostic influence was observed for tumor location, patient age, and gender.
In a Cox’s proportional hazards regression model including age, gender, tumor stage, grade, and location (pelvis vs ureter), squamous and glandular differentiation, as well as the different patterns of invasion, pT-stage >1 [P<0.001, risk ratio (RR)=4.02, 95% confidence interval (CI)=1.82–8.84] and the infiltrative pattern of invasion (P<0.001, RR=3.88, 95% CI=1.87–8.05) proved to be independent predictors of metastatic disease. Patients with UCs showing a nodular pattern of invasion were less likely to develop disease progression but this difference was not statistically significant (P=0.16, RR=0.39, 95% CI=0.11–1.43). Tumor grade and location and presence of squamous and/or glandular differentiation lacked independent influence on patient outcome.
Discussion
According to literature, metastatic disease occurs in 19–54% of upper tract urothelial cancers and a significant proportion of patients eventually die due to tumor dissemination [6, 8, 13–15, 31, 32, 34, 35, 37]. Thus, the identification of independent prognostic factors is an essential step for the evaluation of affected patients not only to predict disease evolution, thus aiding surveillance strategies, but also to identify subgroups that might benefit from adjuvant cancer therapy.
Primary squamous cell carcinoma and adenocarcinoma of the renal pelvis and ureter, defined as tumors showing pure squamous or pure glandular phenotype, are highly uncommon, representing less than 1% of all primary tumors of the upper urinary tract [36]. Their pathogenesis was related to urothelial metaplasia due to long-standing chronic irritation and/or inflammation leading to dysplasia (intraepithelial neoplasia) and ultimately to squamous cell carcinoma or adenocarcinoma [28]. Thus, medical history of affected patients commonly discloses information regarding chronic pyelonephritis and/or nephrolithiasis. Patients often present at an advanced stage of the disease and the outcome is generally poor [23, 33, 38, 40].
In contrast, aberrant squamous and/or glandular differentiation in otherwise typical urothelial cancers is by far more common, occurring in 7–60% of bladder [1, 9, 22, 26, 29, 30, 42, 45] and 10–15% of upper urinary tract UCs [7, 11]. In our series, squamous or glandular differentiation occurred in 74/268 (28%) upper urinary tract tumors, its presence being significantly correlated with high tumor stage and grade. Both squamous and glandular differentiation indicated poor prognosis in univariate analysis. However, multivariate analysis revealed that neither squamous nor glandular differentiation possessed independent influence on patient outcome. Our data are in line with a previous study investigating bladder cancer by Mazzucchelli et al. [30] who reported a significant correlation between squamous differentiation and prognosis in univariate analysis (P=0.05), but not in multivariate analysis.
The high frequency of squamous and/or glandular differentiation in otherwise typical urothelial cancers is not easy to understand because the urinary tract is normally exclusively lined by urothelial cells. To bring light in this topic, Kunze and Francksen [21, 22] systematically investigated carcinoma tissues from human and rat urinary bladder. The authors were able to show that the underlying histogenetic principle is based on the pluripotent metaplastic potential of normal and neoplastic urothelium to undergo several pathways of cellular and architectural differentiation. By demonstrating a direct conversion of typical urothelial carcinoma cells into squamous and/or glandular cells, they concluded that squamous and glandular differentiation develop by a metaplastic process within preexisting conventional UC. This process occurs during tumor progression and dedifferentiation, most probably owing to the embryologic origin of the urinary tract from pluripotent tissues of the cloacal endoderm and the mesodermal Wolffian ducts.
The infiltrative pattern according to Jiminez et al. [17] was significantly associated with the development of metastatic disease and proved to be a new independent prognostic marker that can be determined in routinely H&E-stained sections and is thus easily applicable worldwide. The original analysis by Jiminez et al. [17] and a subsequent study by Krüger et al. [20], which were both restricted to bladder tumors, revealed comparable results. The infiltrative pattern serves as an independent histological prognosticator with a relative risk comparable to that of tumor stage, emphasizing the necessity for pathologists to comment specifically on its presence (or absence).
Tumor heterogeneity represents a well-known phenomenon in urothelial cancers and a significant proportion of tumors in our study and in the previous reports on bladder cancer displayed two or more patterns of invasion. For this reason, a major and a minor pattern was recorded for each patient in both previous reports [17, 20]. However, because both previous studies clearly showed that the presence alone of a minor infiltrative component had the same impact on patient outcome as the presence of a major infiltrative component, we recorded only the most aggressive type of tumor invasion (infiltrative > trabecular > nodular) to improve practicability of the system in daily routine work. In contrast to Krüger et al. [20] who suggested an abbreviated two-tiered classification of invasion (infiltrative vs noninfiltrative), we retained the original three-tiered system because analogous to the negative prognostic effect of the infiltrative pattern, the nodular pattern indicated a tendency toward a more favorable outcome.
In summary, tumor stage and the infiltrative pattern of invasion significantly correlated with advanced disease and enhanced local and distant metastatic spread, clearly indicating that the pattern of invasion is a reliable prognostic factor for patients with upper urinary tract cancer. In contrast, the presence of squamous and/or glandular invasion did not prove independent influence on patient outcome. The pattern of invasion should be commented upon separately in the pathology report.
References
Billis A, Schenka AA, Ramos CC, Carneiro LT, Araujo V (2001) Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance intransurethral resections of the bladder. Int Urol Nephrol 33:631–633
Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O, Ogreid P (2003) Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 169:1291–1294
Charbit L, Gendreau MC, Mee S, Cukier J (1991) Tumors of the upper urinary tract: 10 years of experience. J Urol 146:1243–1246
Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL, Bostwick DG (2000) Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88:1663–1770
Corrado F, Ferri C, Mannini D, Corrado G, Bertoni F, Bacchini P, Lelli G, Lieber MM, Song JM (1991) Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol 145:1159–1163
Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R (1995) Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 46:796–800
Das AK, Carson CC, Bolick D, Paulson DF (1990) Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer 66:1919–1923
Fiori E, Cavallaro G, Paparelli C, Decesare A, Bononi M, Galati G, Tiziano G, Cavallaro A, Cangemi V (2004) Significance of T stadium and grading as prognostic factors in transitional cell carcinoma of the ureter. Anticancer Res 24:1921–1924
Fung CY, Shipley WU, Young RH, Griffin PP, Convery KM, Kaufman DS, Althausen AF, Heney NM, Prout GR Jr (1991) Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9:1533–1542
Genega EM, Porter CR (2002) Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review. Am J Clin Pathol 117(Suppl):S36–S48
Genega EM, Kapali M, Torres-Quinones M, Huang WC, Knauss JS, Wang LP, Raghunath PN, Kozlowski C, Malkowicz SB, Tomaszewski JE (2005) Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney. Mod Pathol 18:11–18
Guinan P, Vogelzang NJ, Randazzo R, Sener S, Chmiel J, Fremgen A, Sylvester J (1992) Renal pelvic cancer: a review of 611 patients treated in Illinois 1975–1985. Cancer incidence and end results committee. Urology 40:393–399
Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG (1998) Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52:594–601
Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper urinary tract urothelial tumors. Cancer 62:2016–2020
Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CP, Shuin T (2002) The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 8:1863–1870
Jenkins BJ, Martin JE, Baithun SI, Zuk RJ, Oliver RT, Blandy JP (1990) Prediction of response to radiotherapy in invasive bladder cancer. Br J Urol 65:345–348
Jimenez RE, Gheiler E, Oskanian P, Tiguert R, Sakr W, Wood DP Jr, Pontes JE, Grignon DJ (2000) Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24:980–987
Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47:155–169
Krogh J, Kvist E, Rye B (1991) Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences. Br J Urol 67:23–36
Krüger S, Noack F, Bohle A, Feller AC (2004) Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Oncol Rep 12:609–613
Kunze E (1998) Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder. Exp Toxicol Pathol 50:341–355
Kunze E, Francksen B (2002) Histogenesis of nonurothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas. A histopathological and immunohistochemical study. Urol Res 30:66–78
Lauritzen AF, Kvist E, Bredesen J, Luke M (1987) Primary carcinoma of the upper urinary tract. Acta Pathol Microbiol Immunol Scand [A] 95:7–10
Lee SH, Lin JS, Tzai TS, Chow NH, Tong YC, Yang WH, Chang CC, Cheng HL (1996) Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur Urol 29:266–270
Logothetis CJ, Dexeus FH, Chong C, Sella A, Ayala AG, Ro JY, Pilat S (1989) Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M. D. Anderson experience. J Urol 141:33–37
Lopez-Beltran A, Martin J, Garcia J, Toro M (1988) Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen. Histol Histopathol 3:63–68
Lopez-Beltran A, Sauter G, Gasser T, Hartmann A, Schmitz-Dräger BJ, Helpap B, Ayala AG, Tamboli P, Knowles MA, Sidransky D, Cordon-Cardo C, Jones PA, Cairns P, Simon R, Amin MB, Tyczynski JE (2004) Tumours of the urinary system. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. IARC, Lyon, pp 93–109
Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guille F (2005) Non-transitional cell bladder carcinomas. BJU Int 95:497–502
Martin JE, Jenkins BJ, Zuk RJ, Blandy JP, Baithun SI (1989) Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 42:250–253
Mazzucchelli L, Bacchi M, Studer UE, Markwalder R, Sonntag RW, Kraft R (1994) Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy. Int J Cancer 57:15–20
Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S (1998) The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol 82:494–498
Mullerad M, Russo P, Golijanin D, Chen HN, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, Kattan MW, Dalbagni G (2004) Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 172:2177–2181
Nativ O, Reiman HM, Lieber MM, Zincke H (1991) Treatment of primary squamous cell carcinoma of the upper urinary tract. Cancer 68:2575–2578
Olgac S, Mazumdar M, Dalbagni G, Reuter VE (2004) Urothelial carcinoma of the renal pelvis. A clinicopathologic study of 130 cases. Am J Surg Pathol 28:1545–1552
Ozsahin M, Zouhair A, Villa S, Storme G, Chauvet B, Taussky D, Gouders D, Ries G, Bontemps P, Coucke PA, Mirimanoff RO (1999) Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 35:738–743
Papadopoulos I, Wirth B, Weichert-Jacobsen K, Loch T, Wacker HH (1996) Primary squamous cell carcinoma of the ureter and squamous adenocarcinoma of the renal pelvis: 2 case reports. J Urol 155:288–289
Racioppi M, D’Addessi A, Alcini A, Destito A, Alcini E (1997) Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol 80:707–711
Raghavendran M, Rastogi A, Dubey D, Chaudhary H, Kumar A, Srivastava A, Mandhani A, Krishnani N, Kapoor R (2003) Stones associated renal pelvic malignancies. Indian J Cancer 40:108–112
Sakamoto N, Tsuneyoshi M, Enjoji M (1992) Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology 21:135–141
Sivaramakrishna B, Aron M, Ansari MS, Seth A, Goel R, Mundada OP, Balchander (2004) Squamous cell carcinoma of the renal pelvis manifesting after percutaneous nephrolithotomy for long standing calculus. Int Urol Nephrol 36:149–151
Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
Starklint H, Kjaergaard J, Jensen NK (1976) Types of metaplasia in forty urothelial bladder carcinomas. A systematic histological investigation. Acta Pathol Microbiol Scand [A] 84:137–142
Strobel SL, Jasper WS, Gogate SA, Sharma HM (1984) Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features. Arch Pathol Lab Med 108:697–700
Tosoni I, Wagner U, Sauter G, Egloff M, Knonagel H, Alund G, Bannwart F, Mihatsch MJ, Gasser TC, Maurer R (2000) Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 85:48–53
Young RH, Eble JN (1991) Unusual forms of carcinoma of the urinary bladder. Hum Pathol 22:948–965
Acknowledgements
The authors thank Mr. R. Christof and Ms. A. Kaps for photographic expertise and excellent technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Langner, C., Hutterer, G., Chromecki, T. et al. Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 448, 604–611 (2006). https://doi.org/10.1007/s00428-006-0150-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-006-0150-4